---
figid: PMC6128202__cns-03-123-g1
figlink: /pmc/articles/PMC6128202/figure/F0001/
number: F1
caption: 'Receptor tyrosine kinases (i.e., EGFR, VEGFR, PDGFR) signal through a MAPK
  cascade to promote cell proliferation, survival, angiogenesis, and differentiation.
  In gliomas, this pathway is mutated such that it is deregulated and overactivated,
  leaving DNA transcription unchecked. NF-1 is normally a brake that inhibits Ras,
  but is often mutated in gliomas and thus is nonfunctional. The tyrosine kinases
  also signal through PI3K, which phosphorylates PIP2 to the active PIP3, which goes
  on to activate nuclear transcription through mTOR. This pathway is kept in check
  by PTEN, but mutations in gliomas result in constitutively active PI3K or an inactive
  PTEN. NF-κB is normally found in the cytoplasm bound with an inhibitor-α, but when
  activated the inhibitor-α and the free NF-kB can then translocate to the nucleus
  to regulate transcription. Notch pathway activation results in the cleavage of the
  cytoplasmic domain of the transmembrane receptor by γ-secretase, which then translocates
  to the nucleus to affect transcription. In terms of direct nuclear regulation, p53
  is mutated in a majority of gliomas and DNA damage goes unregulated allowing continuously
  new mutations to occur. Lastly, Rb is a brake that keeps transcription off and is
  normally inhibited by cyclins that promote transcription. p16 normally inhibits
  the cyclin proteins to keep the cycle in check, but p16 is often mutated in gliomas,
  thereby leading to deregulated proliferation. In the end, all the various treatment
  strategies discussed go after one of these cascades either directly or indirectly.EGFR:
  EGF receptor; PDGFR: PDGF receptor; PIP2: Phosphatidylinositol 4,5-bisphosphate;
  PIP3: Phosphatidylinositol 3,4,5-bisphosphate; PTEN: Phosphate and tensin homolog;
  VEGFR: VEGF receptor.'
pmcid: PMC6128202
papertitle: 'Molecular and genetic pathways in gliomas: the future of personalized
  therapeutics.'
reftext: Ryan Grant, et al. CNS Oncol. 2014 Mar;3(2):123-136.
pmc_ranked_result_index: '58599'
pathway_score: 0.9337729
filename: cns-03-123-g1.jpg
figtitle: Main signaling pathways affected in high-grade gliomas
year: '2014'
organisms: Homo sapiens
ndex: 5cca68f9-df09-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6128202__cns-03-123-g1.html
  '@type': Dataset
  description: 'Receptor tyrosine kinases (i.e., EGFR, VEGFR, PDGFR) signal through
    a MAPK cascade to promote cell proliferation, survival, angiogenesis, and differentiation.
    In gliomas, this pathway is mutated such that it is deregulated and overactivated,
    leaving DNA transcription unchecked. NF-1 is normally a brake that inhibits Ras,
    but is often mutated in gliomas and thus is nonfunctional. The tyrosine kinases
    also signal through PI3K, which phosphorylates PIP2 to the active PIP3, which
    goes on to activate nuclear transcription through mTOR. This pathway is kept in
    check by PTEN, but mutations in gliomas result in constitutively active PI3K or
    an inactive PTEN. NF-κB is normally found in the cytoplasm bound with an inhibitor-α,
    but when activated the inhibitor-α and the free NF-kB can then translocate to
    the nucleus to regulate transcription. Notch pathway activation results in the
    cleavage of the cytoplasmic domain of the transmembrane receptor by γ-secretase,
    which then translocates to the nucleus to affect transcription. In terms of direct
    nuclear regulation, p53 is mutated in a majority of gliomas and DNA damage goes
    unregulated allowing continuously new mutations to occur. Lastly, Rb is a brake
    that keeps transcription off and is normally inhibited by cyclins that promote
    transcription. p16 normally inhibits the cyclin proteins to keep the cycle in
    check, but p16 is often mutated in gliomas, thereby leading to deregulated proliferation.
    In the end, all the various treatment strategies discussed go after one of these
    cascades either directly or indirectly.EGFR: EGF receptor; PDGFR: PDGF receptor;
    PIP2: Phosphatidylinositol 4,5-bisphosphate; PIP3: Phosphatidylinositol 3,4,5-bisphosphate;
    PTEN: Phosphate and tensin homolog; VEGFR: VEGF receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NOTCH4
  - NOTCH1
  - CDKN2A
  - NF1
  - NFKB1
  - NOTCH2
  - MTOR
  - NOTCH3
  - TP53
  - PIK3CG
  - PIK3R3
  - KDR
  - MAPK3
  - PDGFRA
  - MAP2K2
  - MAPK9
  - MAPK10
  - MAPK8
  - MAPK11
  - SIRT2
  - PDGFRB
  - HDAC6
  - HDAC5
  - FLT4
  - CDK4
  - CCND1
  - CCND2
  - CCND3
  - EGFR
  - MAPK1
  - RAF1
  - BRAF
  - HRAS
  - KRAS
  - PIK3R6
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - HDAC2
  - SIRT7
  - ARAF
  - MAPK13
  - MAPK12
  - MAP2K3
  - MAP2K6
  - NRAS
  - FLT1
  - MAPK14
  - AKT1
  - AKT3
  - SIRT1
  - HDAC1
  - HDAC11
  - SIRT6
  - HDAC7
  - HDAC8
  - AKT2
  - MAP2K7
  - MAP2K4
  - MAP2K1
  - HDAC9
  - SIRT4
  - SIRT3
  - HDAC3
  - SIRT5
  - HDAC10
  - MAP2K5
  - NFKBIA
  - HDAC4
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Melanoma
  - Noonan syndrome
genes:
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH4
  entrez: '4855'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: p16
  symbol: p16
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: NF1
  symbol: NF1
  source: hgnc_symbol
  hgnc_symbol: NF1
  entrez: '4763'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH2
  entrez: '4853'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH3
  entrez: '4854'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT2
  entrez: '22933'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC6
  entrez: '10013'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC5
  entrez: '10014'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: CDK4
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC2
  entrez: '3066'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT7
  entrez: '51547'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: (MAPKK)
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K3
  entrez: '5606'
- word: (MAPKK)
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K6
  entrez: '5608'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT1
  entrez: '23411'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC1
  entrez: '3065'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC11
  entrez: '79885'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT6
  entrez: '51548'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC7
  entrez: '51564'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC8
  entrez: '55869'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: (MAPKK)
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K7
  entrez: '5609'
- word: (MAPKK)
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K4
  entrez: '6416'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC9
  entrez: '9734'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT4
  entrez: '23409'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT3
  entrez: '23410'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC3
  entrez: '8841'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT5
  entrez: '23408'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC10
  entrez: '83933'
- word: (MAPKK)
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K5
  entrez: '5607'
- word: IKB-a
  symbol: IkappaBalpha
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC4
  entrez: '9759'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Melanoma
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC6128202__F1
redirect_from: /figures/PMC6128202__F1
figtype: Figure
---
